MAUI, Hawaii, Feb. 7 /PRNewswire-FirstCall/ -- Bioponic Phytoceuticals, Inc. ("Bioponic" or "the Company") (OTC: BPYT - News) today announced that sales for the month of January 2008 increased 40% compared to sales for the month of January 2007.
We achieved a record breaking month of sales in January, primarily from continued success of our Flight Spray product. We are also gaining market traction for our latest product release, an all-natural solution for baby care marketed under the Gentle Mother(TM) line," said Steven M. Schorr, Chairman & CEO of Bioponic. "Bioponic is now focused on establishing distribution relationships that will greatly expand the availability of multiple product lines, including O-Spray(TM), Throat Note(TM), Gentle Mother(TM), Hawaiian Healing Mist, and Noni Healing Tonic for placement into national health food stores and natural products retailers. Our goal is take our core product lines and position them for exponential sales growth, much like Flight Spray achieved when it gained a presence in over 1,000 points of distribution."
"We have secured an agreement with a leading wholesaler-distributor in the Natural Food industry to bring five of our all natural health and wellness product lines, representing 11 products, into 1,000 retail stores in the Western U.S. We expect the results of this distributorship, and other marketing channels, will lead to aggressive total revenue growth for Bioponic in 2008," said Schorr.
Bioponic Phytoceuticals is engaged in the formulation, production and distribution of natural products for sale in the Complementary Alternative Medicine markets. The Company has developed a new patent pending healing modality "Bioresonant Phytotherapeutics(TM)" and has several branded product lines currently in national distribution. For further information, please see www.bioponic.com.
All statements other than statements of historical fact included in this press release are "forward-looking statements" within the meaning of federal securities laws. Such forward-looking statements are subject to a number of risks and uncertainties, some of which are beyond the Company's control.
CONTACT: Steven M. Schorr, CEO, Bioponic Phytoceuticals, +1-808-876-1711, firstname.lastname@example.org or Geoffrey Eiten, Investor Relations, OTC Financial Network, +1-781-444-6100x613, email@example.com, http://www.otcfn.com/bpyt.